{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:53:38Z","timestamp":1789527218550,"version":"build-2803163510"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.imlet.2017.05.010","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T17:46:44Z","timestamp":1494956804000},"page":"13-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Biomarkers for rheumatoid arthritis: From molecular processes to diagnostic applications-current concepts and future perspectives"],"prefix":"10.1016","volume":"189","author":[{"given":"Britt","family":"Nakken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidar","family":"Bosnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margit","family":"Zeher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Szodoray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2017.05.010_bib0005","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2017.05.010_bib0010","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(09)60008-8","article-title":"Rheumatoid arthritis","volume":"373","author":"Klareskog","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2017.05.010_bib0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrrheum.2011.28","article-title":"Rheumatoid arthritis: are ACPA-positive and ACPA-negative RA the same disease?","volume":"7","author":"Daha","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0020","doi-asserted-by":"crossref","first-page":"R180","DOI":"10.1186\/ar3505","article-title":"Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?","volume":"13","author":"De Rooy","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.05.010_bib0025","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis. Rheum."},{"key":"10.1016\/j.imlet.2017.05.010_bib0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/art.10092","article-title":"Treating rheumatoid arthritis early: a window of opportunity?","volume":"46","author":"O\u2019Dell","year":"2002","journal-title":"Arthritis. Rheum."},{"key":"10.1016\/j.imlet.2017.05.010_bib0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1741-7015-12-25","article-title":"Early start and stop of biologics: has the time come?","volume":"12","author":"van Vollenhoven","year":"2014","journal-title":"BMC Med."},{"key":"10.1016\/j.imlet.2017.05.010_bib0040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13075-015-0707-1","article-title":"Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?","volume":"17","author":"Nagy","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.05.010_bib0045","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1699-0463.1940.tb01475.x","article-title":"On the occurrence of a factor in human serum activating the specific agglutintion of sheep blood corpuscles","volume":"17","author":"Waaler","year":"1940","journal-title":"Acta Pathol. Microbiol. Scand."},{"key":"10.1016\/j.imlet.2017.05.010_bib0050","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/0003-4819-152-7-201004060-00010","article-title":"Systematic review: accuracy of anti-citrullinated Peptide antibodies for diagnosing rheumatoid arthritis","volume":"152","author":"Whiting","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.imlet.2017.05.010_bib0055","doi-asserted-by":"crossref","first-page":"e5244","DOI":"10.1136\/bmj.e5244","article-title":"Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study","volume":"345","author":"Nielsen","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.imlet.2017.05.010_bib0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3899\/jrheum.101070","article-title":"Diagnostic and prognostic value of antibodies and soluble biomarkers in undifferentiated peripheral inflammatory arthritis: a systematic review","volume":"87","author":"Schoels","year":"2011","journal-title":"J. Rheumatol. Suppl."},{"key":"10.1016\/j.imlet.2017.05.010_bib0065","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/0002-9343(91)90190-9","article-title":"The rheumatoid factor: an analysis of clinical utility","volume":"91","author":"Shmerling","year":"1991","journal-title":"Am. J. Med."},{"key":"10.1016\/j.imlet.2017.05.010_bib0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/08916930400022574","article-title":"Rheumatoid factor on a daily basis","volume":"38","author":"Renaudineau","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.imlet.2017.05.010_bib0075","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1155\/2013\/726598","article-title":"Rheumatoid factors: clinical applications","volume":"35","author":"Ingegnoli","year":"2013","journal-title":"Dis. Markers"},{"key":"10.1016\/j.imlet.2017.05.010_bib0080","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","article-title":"The cryoglobulinaemias","volume":"379","author":"Ramos-Casals","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2017.05.010_bib0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1749-6632.1969.tb43092.x","article-title":"Distribution of rheumatoid factor activity in nonrheumatoid states","volume":"168","author":"Bartfeld","year":"1969","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.imlet.2017.05.010_bib0090","first-page":"32","article-title":"Advantages and limitations of quantitative measures to assess rheumatoid arthritis \u2013 joint counts, radiographs, laboratory tests, and patient","volume":"64","author":"Pincus","year":"2006","journal-title":"Bull. NYU. Hosp. Jt. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0095","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","article-title":"Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis","volume":"146","author":"Nishimura","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.imlet.2017.05.010_bib0100","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2006.051391","article-title":"Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review","volume":"65","author":"Avouac","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0105","first-page":"S59","article-title":"Autoantibodies in early arthritis: advances in diagnosis and prognostication","volume":"21","author":"Hueber","year":"2003","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/ard.2005.038851","article-title":"The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis","volume":"65","author":"Chen","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/ard.2004.023523","article-title":"Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis","volume":"64","author":"De Rycke","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0120","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.23.4.302","article-title":"A new serum factor in patients with rheumatoid arthritis: the antiperinuclear factor","volume":"23","author":"Nienhuis","year":"1964","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/bmj.2.6182.97","article-title":"Anti-keratin antibodies in rheumatoid arthritis","volume":"2","author":"Young","year":"1979","journal-title":"Br. Med. J."},{"key":"10.1016\/j.imlet.2017.05.010_bib0130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12016-007-8022-5","article-title":"Anti-citrullinated protein antibodies in rheumatoid arthritis: as good as it gets?","volume":"34","author":"Szekanecz","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0135","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.3899\/jrheum.100399","article-title":"Is it necessary to combine detection of anticitrullinated protein antibodies in the diagnosis of rheumatoid arthritis?","volume":"37","author":"Zhao","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0140","first-page":"689","article-title":"The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis","volume":"17","author":"van Jaarsveld","year":"1999","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0145","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/ard.62.5.427","article-title":"Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis","volume":"62","author":"Vencovsk\u00fd","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0150","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI117969","article-title":"The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies","volume":"95","author":"Sebbag","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.05.010_bib0155","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.05.010_bib0160","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4049\/jimmunol.162.1.585","article-title":"The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues","volume":"162","author":"Girbal-Neuhauser","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0165","first-page":"1027","article-title":"The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis","volume":"21","author":"Despr\u00e9s","year":"1994","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0170","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/ar122","article-title":"Insights into rheumatoid arthritis derived from the Sa immune system","volume":"2","author":"M\u00e9nard","year":"2000","journal-title":"Arthritis Res."},{"key":"10.1016\/j.imlet.2017.05.010_bib0175","first-page":"7","article-title":"Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis","volume":"26","author":"Hayem","year":"1999","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0180","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/ar93","article-title":"Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset","volume":"2","author":"Goldbach-Mansky","year":"2000","journal-title":"Arthritis Res."},{"key":"10.1016\/j.imlet.2017.05.010_bib0185","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar1149","article-title":"Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin","volume":"6","author":"Vossenaar","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.05.010_bib0190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5041\/RMMJ.10255","article-title":"ACPAs are much more than diagnostic autoantibodies","volume":"7","author":"Watad","year":"2016","journal-title":"Rambam Maimonides Med. J."},{"key":"10.1016\/j.imlet.2017.05.010_bib0195","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.autrev.2015.01.013","article-title":"Citrullination and autoimmunity","volume":"14","author":"Valesini","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2017.05.010_bib0200","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/bies.10357","article-title":"PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease","volume":"25","author":"Vossenaar","year":"2003","journal-title":"Bioessays"},{"key":"10.1016\/j.imlet.2017.05.010_bib0205","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/ard.2011.151712","article-title":"Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis","volume":"71","author":"Darrah","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0210","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.1101400","article-title":"Human PAD4 regulates histone arginine methylation levels via demethylimination","volume":"306","author":"Wang","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.imlet.2017.05.010_bib0215","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/ar75","article-title":"Death, autoantigen modifications, and tolerance","volume":"2","author":"Utz","year":"2000","journal-title":"Arthritis Res."},{"key":"10.1016\/j.imlet.2017.05.010_bib0220","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1084\/jem.20100239","article-title":"PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps","volume":"207","author":"Li","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2017.05.010_bib0225","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3389\/fimmu.2016.00485","article-title":"NETosis as source of autoantigens in rheumatoid arthritis","volume":"7","author":"Corsiero","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0230","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/annrheumdis-2012-202765","article-title":"Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps","volume":"73","author":"Pratesi","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0235","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/annrheumdis-2012-202726","article-title":"Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis","volume":"73","author":"Quirke","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"March","key":"10.1016\/j.imlet.2017.05.010_bib0240","article-title":"Autoantibodies against citrullinated histone H3 in rheumatoid arthritis and periodontitis patients","author":"Janssen","year":"2017","journal-title":"J. Clin. Periodontol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0245","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/art.27439","article-title":"Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation","volume":"62","author":"Andrade","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2017.05.010_bib0250","first-page":"969","article-title":"Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis","volume":"35","author":"Zhao","year":"2008","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0255","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1136\/annrheumdis-2014-205385","article-title":"Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology","volume":"74","author":"Konig","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0260","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.4049\/jimmunol.166.6.4177","article-title":"The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin","volume":"166","author":"Masson-Bessi\u00e8re","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/art.37720","article-title":"The rheumatoid arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E myeloid nuclear differentiation antigen, and \u03b2-actin","volume":"65","author":"van Beers","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.05.010_bib0270","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3899\/jrheum.120751","article-title":"Screening citrullinated proteins in synovial tissues of rheumatoid arthritis using 2-dimensional western blotting","volume":"40","author":"Chang","year":"2013","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0275","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1002\/art.22983","article-title":"Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1 PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation","volume":"56","author":"Foulquier","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.05.010_bib0280","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1136\/annrheumdis-2012-201906","article-title":"Citrullination enhances the pro-inflammatory response to fibrin in rheumatoid arthritis synovial fibroblasts","volume":"72","author":"Sanchez-Pernaute","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0285","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.0105-2896.2009.00853.x","article-title":"Antibodies to citrullinated proteins: molecular interactions and arthritogenicity","volume":"233","author":"Uysal","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imlet.2017.05.010_bib0290","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1196\/annals.1443.013","article-title":"Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis","volume":"1143","author":"van Venrooij","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.imlet.2017.05.010_bib0295","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/BOR.0000000000000277","article-title":"The role of anticitrullinated protein antibodies in the early stages of rheumatoid arthritis","volume":"28","author":"Dekkers","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0300","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/BOR.0b013e3282fbd22a","article-title":"Antibodies to citrullinated proteins in arthritis: pathology and promise","volume":"20","author":"Klareskog","year":"2008","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0305","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.05.010_bib0310","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1002\/art.27552","article-title":"Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and \u03b1-enolase: implications for autoimmunity in rheumatoid arthritis","volume":"62","author":"Wegner","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.05.010_bib0315","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.autrev.2009.04.006","article-title":"Anti-citrullinated protein\/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis","volume":"9","author":"Szodoray","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2017.05.010_bib0320","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/ard.2009.116384","article-title":"The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis","volume":"69","author":"van der Woude","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0325","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1136\/annrheumdis-2011-201109","article-title":"Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the \u2018Orencia and Rheumatoid Arthritis' registry","volume":"71","author":"Gottenberg","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0330","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jbspin.2014.06.001","article-title":"High anti-CCP antibody titres predict good response to rituximab in patients with active rheumatoid arthritis","volume":"81","author":"Gardette","year":"2014","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.imlet.2017.05.010_bib0335","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/03009742.2012.723746","article-title":"Anti-cyclic citrullinated peptide antibodies: a comparison of different assays for the diagnosis of rheumatoid arthritis","volume":"42","author":"Debaugnies","year":"2013","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0340","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.cca.2012.02.002","article-title":"Analytical and clinical comparison of anti-CCP assays with rheumatoid factor for the diagnosis of rheumatoid arthritis","volume":"413","author":"Block","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.imlet.2017.05.010_bib0345","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1517\/17530059.2012.694423","article-title":"The role of anti-cyclic citrullinated peptide (CCP) antibodies in early detection of rheumatoid arthritis: an overview of the INOVA Diagnostics Inc. QUANTA Lite CCP assays","volume":"6","author":"Gilliam","year":"2012","journal-title":"Expert Opin. Med. Diagn."},{"key":"10.1016\/j.imlet.2017.05.010_bib0350","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrrheum.2011.76","article-title":"Anti-CCP antibodies: the past, the present and the future","volume":"7","author":"van Venrooij","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0355","first-page":"1658","article-title":"Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis","volume":"34","author":"So\u00f3s","year":"2007","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0360","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/ard.2009.113092","article-title":"Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study","volume":"69","author":"Syversen","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0365","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/ard.2008.103283","article-title":"Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review","volume":"69","author":"Luime","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0370","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.autrev.2012.02.015","article-title":"Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature","volume":"11","author":"Bartoloni","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"March","key":"10.1016\/j.imlet.2017.05.010_bib0375","article-title":"Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis","volume":"9","author":"Trouw","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0380","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/annrheumdis-2016-209794","article-title":"Rheumatoid arthritis phenotype at presentation differs depending on the number of autoantibodies present","volume":"76","author":"Derksen","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"February","key":"10.1016\/j.imlet.2017.05.010_bib0385","article-title":"Carbamylation of vimentin is inducible by smoking and represents an independent autoantigen in rheumatoid arthritis","author":"Ospelt","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"April","key":"10.1016\/j.imlet.2017.05.010_bib0390","article-title":"Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies","author":"Nakabo","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imlet.2017.05.010_bib0395","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl. 2","key":"10.1016\/j.imlet.2017.05.010_bib0400","doi-asserted-by":"crossref","first-page":"ii132","DOI":"10.1136\/annrheumdis-2012-202349","article-title":"Autoimmunity in rheumatoid arthritis: different antigens-common principles","volume":"72","author":"Trouw","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0405","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.37830","article-title":"Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis","volume":"65","author":"Shi","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.05.010_bib0410","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/annrheumdis-2015-208870","article-title":"The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor","volume":"76","author":"Ajeganova","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0415","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.autrev.2012.05.007","article-title":"Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis","volume":"12","author":"Trouw","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2017.05.010_bib0420","first-page":"219","article-title":"Consideration of pathogenesis of rheumatoid arthritis as collagen autoimmunity","volume":"139","author":"Steffen","year":"1970","journal-title":"Z. Immunitatsforsch Allerg. Klin. Immunol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0425","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1136\/ard.2007.084277","article-title":"Anti-collagen type II antibodies in patients with very early synovitis","volume":"67","author":"Raza","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0430","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/ard.39.3.201","article-title":"Incidence of serum antibodies to native type I and type II collagens in patients with inflammatory arthritis","volume":"39","author":"Clague","year":"1980","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0435","first-page":"2090","article-title":"IgG subclasses of antibodies to type II collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases","volume":"24","author":"Cook","year":"1997","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0440","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/ard.2006.064782","volume":"66","author":"Mullazehi","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0445","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1186\/ar3825","article-title":"Anti-type II collagen antibodies are associated with early radiographic destruction in rheumatoid arthritis","volume":"14","author":"Mullazehi","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.05.010_bib0450","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/anr.1780321204","article-title":"Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis","volume":"32","author":"Hassfeld","year":"1989","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.05.010_bib0455","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1172\/JCI115921","article-title":"Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex","volume":"90","author":"Steiner","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.05.010_bib0460","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/art.10241","article-title":"Value of laboratory tests in early prediction of rheumatoid arthritis","volume":"47","author":"Saraux","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"604305","key":"10.1016\/j.imlet.2017.05.010_bib0465","article-title":"Immunodiagnostic significance of anti-RA33 autoantibodies in Saudi patients with rheumatoid arthritis","volume":"2015","author":"Al-Mughales","year":"2015","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.imlet.2017.05.010_bib0470","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/ard.2008.100677","article-title":"Autoantibody profiling in patients with very early rheumatoid arthritis: a follow-up study","volume":"69","author":"Nell-Duxneuner","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.imlet.2017.05.010_bib0475","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar551","article-title":"Autoantibodies in rheumatoid arthritis and their clinical significance","volume":"4","author":"Steiner","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.imlet.2017.05.010_bib0480","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/ard.2005.035691","article-title":"Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis","volume":"64","author":"Nell","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0485","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.4049\/jimmunol.166.3.1492","article-title":"The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis","volume":"166","author":"Corrigall","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0490","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/1529-0131(200104)44:4<761::AID-ANR132>3.0.CO;2-S","article-title":"The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis","volume":"44","author":"Blass","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.05.010_bib0495","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/rheumatology\/keq272","article-title":"Antibodies to the endoplasmic reticulum-resident chaperones calnexin, BiP and Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"49","author":"Weber","year":"2010","journal-title":"Rheumatology (Oxford"},{"issue":"November","key":"10.1016\/j.imlet.2017.05.010_bib0500","article-title":"Diagnostic value of autoantibodies combined detection for rheumatoid arthritis","author":"Sun","year":"2016","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.imlet.2017.05.010_bib0505","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1186\/ar3520","article-title":"Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis","volume":"13","author":"Shoda","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.05.010_bib0510","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/90696","article-title":"Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease","volume":"2","author":"Schaller","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0515","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/ar72","article-title":"A new model for rheumatoid arthritis?","volume":"2","author":"McDevitt","year":"2000","journal-title":"Arthritis Res."},{"key":"10.1016\/j.imlet.2017.05.010_bib0520","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3109\/s10165-005-0405-y","article-title":"Clinical characteristics of anti-glucose-6-phosphate isomerase antibody-positive Japanese patients with rheumatoid arthritis","volume":"15","author":"Hayashi","year":"2005","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.imlet.2017.05.010_bib0525","doi-asserted-by":"crossref","first-page":"R110","DOI":"10.1186\/ar2507","article-title":"Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritis","volume":"10","author":"Gy\u00f6rgy","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.05.010_bib0530","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2010.10.003","article-title":"Novel autoantibody markers for early and seronegative rheumatoid arthritis","volume":"36","author":"Somers","year":"2011","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imlet.2017.05.010_bib0535","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/ard.2008.096917","article-title":"New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA","volume":"68","author":"Auger","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.05.010_bib0540","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.autrev.2012.02.009","article-title":"Autoantibodies to PAD4 and BRAF in rheumatoid arthritis","volume":"11","author":"Auger","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2017.05.010_bib0545","doi-asserted-by":"crossref","first-page":"R194","DOI":"10.1186\/ar3165","article-title":"Autoantibodies to BRAF, a new family of autoantibodies associated with rheumatoid arthritis","volume":"12","author":"Charpin","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.05.010_bib0550","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13075-016-1116-9","article-title":"Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis","volume":"18","author":"Bugatti","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.05.010_bib0555","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13075-016-1076-0","article-title":"MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF","volume":"18","author":"Boeters","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.05.010_bib0560","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/annrheumdis-2011-201056","article-title":"Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort","volume":"72","author":"Nicaise-Roland","year":"2013","journal-title":"Ann. Rheum. Dis."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817302079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817302079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T15:57:23Z","timestamp":1692806243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247817302079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":112,"alternative-id":["S0165247817302079"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2017.05.010","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers for rheumatoid arthritis: From molecular processes to diagnostic applications-current concepts and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2017.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}